Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage [Phase 1, Phase 2]

View source ↗

Summary

This update reports a Phase 1/2 clinical trial testing theophylline given during therapeutic hypothermia to reduce neonatal kidney injury in hypoxic-ischemic en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Acute Kidney Injury, HIE | Phase 1, Phase 2 | Status: RECRUITING